High-dose Wegovy leads to substantial weight loss in trial
Nicole Albanese, PharmD, discusses the science behind weight-loss drugs, their potential to treat other addictions as well as ...
GLP-1 drugs do a lot more than just help you lose weight. They can help your heart, brain, and more, but beware what they ...
It hasn't been a great period for investors in Novo Nordisk (NYSE: NVO) despite its ongoing status as one of the ...
The podcast features Numerator Chief Economist Leo Feler, who talks about the potential impact of GLP-1 drugs like Ozempic ...
Canadian public and private insurers have balked at covering certain medication for weight-loss, but that might change as the ...
U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.
Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...
Novo Nordisk A/S’s blockbuster drug Wegovy was targeted for price cuts by the US government and suffered a setback in a new ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback